| abstract |
The present invention relates to biomedicine field, more particularly to polyinosinic acid, the purposes of imiquimod and GDQ in virus immunity mouse model is built.Inventor uses mouse model, using polyinosinic acid, imiquimod and GDQ form " antiviral " immune state, it was found that there is Pulmonary bacterial removing obstacles phenomenon through the experiment mice that polyinosinic acid is administered, additionally, it is observed that polyinosinic acid can mediate the expression of IFNI, and IFNI can finally cause lung to the defense mechanism of Gram positive pathogenic bacterium. |